Director, Pharmacokinetics

Merck Merck · Pharma · PA

Director level role leading a Biotransformation (MetID) group within Drug Metabolism & Pharmacokinetics (DMPK) at Merck. The role focuses on guiding discovery and development projects by elucidating and understanding drug metabolite profiles to ensure safety, optimize efficacy, and meet regulatory expectations. Responsibilities include scientific leadership, overseeing metabolite identification studies using mass spectrometry, integrating findings into drug development, resolving metabolism-related liabilities, collaborating cross-functionally, and leading a team of scientists. Requires a Ph.D. or MS in a related field with extensive industry experience in drug metabolism and metabolite identification.

What you'd actually do

  1. Provide strategic and technical leadership for the biotransformation/metabolite identification function.
  2. Oversee the design and execution of in vitro and in vivo MetID studies to characterize metabolites in relevant matrices (plasma, urine, bile, etc.).
  3. Apply broad drug development expertise to integrate metabolite findings into program decision-making.
  4. Anticipate and address metabolism-related liabilities in drug candidates.
  5. Lead a team of skilled MetID scientists and manage group priorities and resources, ensuring high-quality and timely delivery of metabolite identification results across multiple programs.

Skills

Required

  • Ph.D. in Organic or Analytical Chemistry, Pharmacology, Pharmaceutical Sciences or a related discipline
  • at least 8 years (or an MS degree with > 12 years) of relevant industry experience in drug metabolism
  • significant experience with metabolite identification in a pharmaceutical R&D setting
  • Deep expertise in metabolite identification and biotransformation science
  • Extensive hands-on experience with structural assignment techniques, including purification from biological matrices, LC‑MS/MS and high-resolution mass spectrometry
  • Broad knowledge of ADME and drug metabolism principles across discovery and development
  • Understanding of both non-clinical and clinical aspects of metabolite exposure
  • design of in vitro metabolism studies (e.g. hepatocyte/metabolic stability, enzyme phenotyping)
  • in vivo studies (animal metabolism and human mass balance studies)
  • Familiarity with regulatory guidelines on metabolites (e.g. ICH M3(R2) and FDA MIST guidance)
  • experience ensuring compliance with metabolite safety assessment requirements
  • Proven leadership skills in a scientific setting
  • Prior experience in supervising or mentoring other scientists

Nice to have

  • experience with other modalities (_e.g._ peptide therapeutics)

What the JD emphasized

  • extensive small molecule experience will be critical
  • strong publication record
  • extensive hands-on experience with structural assignment techniques
  • Familiarity with regulatory guidelines on metabolites (e.g. ICH M3(R2) and FDA MIST guidance)